Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
131.73
-0.27 (-0.20%)
Streaming Delayed Price
Updated: 11:24 AM EDT, Sep 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S ADR
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
59
60
Next >
Looking At Novo Nordisk's Recent Unusual Options Activity
March 25, 2024
Via
Benzinga
Uncovering Hidden Gems: 1 AI-Powered Healthcare Stock Set to Dominate the Market
March 25, 2024
Artificial intelligence (AI) could play a big role in medical breakthroughs.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'
March 25, 2024
Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to Jim Cramer.
Via
Benzinga
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
March 25, 2024
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants.
Via
The Motley Fool
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024
Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Decoding 7 Analyst Evaluations For Novo Nordisk
March 20, 2024
Via
Benzinga
Is Novo Nordisk on the Verge of Another Blockbuster Drug?
March 19, 2024
Novo Nordisk just received some positive news for its latest obesity drug, amycretin.
Via
The Motley Fool
Is Viking Therapeutics Stock a Millionaire Maker?
March 24, 2024
Viking Therapeutics has become one of the hottest healthcare stocks of 2024.
Via
The Motley Fool
Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities
March 23, 2024
Shanghai WuXi Biologics has broken ground on a $1.4 billion facility in Singapore. Meanwhile, Novo Nordisk announced plans to invest $556 million to expand its Tianjin city production facility.
Via
Talk Markets
How Are Obesity Drugs And Nvidia Related? Success Of Ozempic, Wegovy Propels Novo Nordisk Foundation To Fund Nvidia-Powered AI Supercomputer For Faster Drug Development
March 22, 2024
Novo Nordisk Foundation partners with Eviden and Nvidia to pioneer AI-driven healthcare solutions. Expect the Gefion supercomputer to revolutionize drug discovery, supported by tech giants and the Novo...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge
March 22, 2024
Legal actions surge against diabetes drug manufacturers Eli Lilly and Novo Nordisk. Patients allege severe complications, including gallbladder issues and gastroparesis, tied to GLP-1 agonists. Over 60...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
March 22, 2024
The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
Via
The Motley Fool
Did Eli Lilly Just One-Up Novo Nordisk?
March 22, 2024
Eli Lilly just partnered with Amazon to help accelerate distribution of its various treatments.
Via
The Motley Fool
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
March 21, 2024
Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now.
Via
InvestorPlace
Medicare Will Cover Weight-Loss Drugs — For Some. Here's What It Means For Novo, Lilly.
March 21, 2024
Novo Nordisk's Wegovy recently gained Food and Drug Administration approval to reduce the risk of cardiovascular problems.
Via
Investor's Business Daily
Wegovy's Success - Medicare Contemplates Covering Novo Nordisk's Semaglutide For Heart Health
March 21, 2024
Medicare considers extending coverage for Novo Nordisk's Wegovy to eligible members with heart disease history. CMS may include anti-obesity drugs under certain Medicare Part D plans. Germany's health...
Via
Benzinga
7 Stocks That Are Creating a Buzz on Wall Street
March 21, 2024
Buy these stocks creating buzz in order to inject some green into your portfolio and give your investment returns a boost.
Via
InvestorPlace
Novo Nordisk's New Weight Loss Drug Could Be Better Than Ozempic and Wegovy
March 21, 2024
Has Novo Nordisk's already red-hot stock become an even better buy?
Via
The Motley Fool
Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions
March 20, 2024
Eli Lilly stock is up 32% so far in 2024 and has risen 318% over three years.
Via
Benzinga
3 Biopharma Stocks Predicted to Soar in Q2 2024
March 20, 2024
These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
March 20, 2024
Via
Benzinga
Novo Nordisk Stock Stalls On Oprah TV Special, But Reddit Traders Believe It's 'Not Done Yet'
March 20, 2024
Retail investors are talking about a slim group of topics on Reddit this week including Novo Nordisk, weight-loss drug Ozempic and talk show host Oprah Winfrey.
Via
Benzinga
Will Novo Nordisk Overtake Eli Lilly as the Most Valuable Healthcare Stock?
March 20, 2024
The gap has been shrinking between these stocks over the past month.
Via
The Motley Fool
Tesla Investor Ross Gerber Backs Ozempic's Potential To Reduce Monthly Food Expenses — Less Eating, More Saving
March 20, 2024
Ross Gerber, a prominent Tesla investor, has suggested that the use of Ozempic could lead to significant cost savings.
Via
Benzinga
3 Juicy Stocks Serving Up 5% Dividends That You Can Snag for $50
March 19, 2024
These dividend stocks selling for under $50 with yields of 5% or more offer a lot to investors at any time making these strong buys.
Via
InvestorPlace
What Retail Apocalypse? 7 Stocks Proving the Doomsayers Wrong.
March 19, 2024
People have said retail is dying for years now but the supposed apocalypse is nowhere to be found with these fast-charging retail stocks.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
Via
Benzinga
Did Novo Nordisk Just Get a Jump on Eli Lilly?
March 19, 2024
A recent FDA announcement may have just put one company in the lead.
Via
The Motley Fool
Exposures
Product Safety
Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: 'For 25 Years, Making Fun Of My Weight Was National Sport'
March 19, 2024
Winfrey dedicated a prime-time special to discussing the stigma surrounding weight loss and the use of drugs like Ozempic and Mounjaro
Via
Benzinga
LifeMD Shares Come Back to Life on GLP-1 Business Growth
March 19, 2024
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024
Via
MarketBeat
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
59
60
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.